Insider Trading & Ownership of Mary Kay Fenton

Location: Cambridge, MA
Summary: The estimated net worth of Mary Kay Fenton is at least $2,877,532 dollars as of 23 Feb 2026. Mary Kay Fenton is the Chief Financial Officer of Cullinan Therapeutics, Inc. and owns shares of Cullinan Therapeutics, Inc. (CGEM) stock worth about $1.72M. Mary Kay Fenton is the Chief Financial Officer of Talaris Therapeutics, Inc. and owns shares of Tourmaline Bio, Inc. (TRML) stock worth about $1.16M.
Signature: /s/ Jacquelyn Sumer, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Mary Kay Fenton files a new Insider Trading report.

Ownership of Mary Kay Fenton

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
CGEM	Cullinan Therapeutics, Inc.	Chief Financial Officer	$1,721,295	-$59,901	-3.4%	20 Feb 2026
TRML	Talaris Therapeutics, Inc.	Chief Financial Officer	$1,156,237			03 Jul 2023
ONCR	Oncorus, Inc.	Director				23 Jun 2022

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.